To evaluate the effect of l-desamino-8-D-arginine vasopressin (DDAVP) on surgical blood loss, 35 hemostatically-normal subjects received 10 μg/M 2 DDAVP or placebo by randomized double-blind ...

DDAVP has repeatedly been shown to improve bleeding time in patients who are actively bleeding or who are being prepared for surgery. DDAVP improves dysfunctional platelet activity by stimulating ...

In the presence of diabetes insipidus, desmopressin (DDAVP) should be administered and the patient should be closely monitored for fluid intake and output, and particularly for serum sodium levels.

In cases like this, a synthetic version of vasopressin called DDAVP (desmopressin) can be prescribed to reduce urination and ...